Coadministration of dengue plus Tdap vaccines feasible, safe in seropositive patients
03 Sep 2021
byStephen Padilla
Concomitant or sequential administration of the combined tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine and the tetravalent dengue vaccine (CYD-TDV; sold under the brand name Dengvaxia) produces similar immunogenicity and safety profiles in baseline dengue seropositive participants, a Philippines study has shown.
Coadministration of dengue plus Tdap vaccines feasible, safe in seropositive patients
03 Sep 2021